Press Releases

NEW YORK – GT Molecular announced Friday that it has been awarded a contract from the US Centers for Disease Control and Prevention to develop digital PCR assays for wastewater surveillance. The multiplex, multi-pathogen assays will be developed for the National Wastewater Surveillance System (NWSS) division of the CDC. The contract could be worth up […]

GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer research, and pathogen detection, was awarded the Center for Disease Control’s (CDC) National Wastewater Surveillance System (NWSS), Multi-Pathogen Assay Development Optimization, Validation, and Support contract. This work will build upon previously successful contracts with the CDC and incorporate emerging public health threat […]

VAF ≤ 0.03% – Affords digital PCR sensitivity in RT-PCR Suitable for tissue, liquid biopsy, and minimal residual disease (MRD) research applications Translational research testing services available For Research Use Only. Not for use in diagnostic procedures. FORT COLLINS, Colo., June 13, 2024 /PRNewswire/ — GT Molecular, Inc., a leader in developing ultra-sensitive PCR assays for cancer research, pathogen detection, […]

GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology testing, pathogen detection, and cancer research is pleased to announce an agreement with Roche to provide a highly multiplexed respiratory panel for wastewater surveillance on the new Roche Digital LightCycler® System. This digital PCR assay kit co-quantifies respiratory pathogens SARS-CoV-2, influenza A, influenza […]

Wastewater surveillance proved to be a valuable tool during the COVID-19 pandemic as the detection of rising levels of SARS-CoV-2 virus mirrored the increase in COVID-19 case counts. During periods of limited clinical testing, wastewater testing provided critical information that indicated the potential for surges in clinical cases and allowed for resource redistribution and hospital preparedness.

GT Molecular joined the burgeoning wastewater-based epidemiology (WBE) field during the early days of the COVID-19 pandemic. The initial validated molecular workflow stemmed from a local collaboration between academia and industry that culminated in a validated service offering spanning 44 states within the Continental United States.

NEW YORK – The US Centers of Disease Control and Prevention is moving forward on a planned expansion of the wastewater infectious disease surveillance efforts it pioneered during the pandemic.
Scaled up to surveil sewage from nearly half of the US population for SARS-CoV-2 transmission, the agency now plans to also track gastrointestinal, respiratory, and antimicrobial resistant pathogens through the rollout of two dozen digital PCR wastewater surveillance targets next year.
CDC’s National Wastewater Surveillance System (NWSS) is currently collaborating with molecular diagnostics developer GT Molecular to create the digital PCR assays, as well as multiplex dPCR panels. The goal is to make the assays available as methods and kits to partners in public health labs for testing.

Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection These kits are for Research Use Only (RUO)Not for use in diagnostic purposes FORT COLLINS, Colo., June 1, 2023 /PRNewswire/ — GT-Plex™ Digital PCR Assay Kit GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing […]

KEY ADVANTAGES High-throughput multiplex detection coupling GT Molecular’s Digital PCR Assays with the Ceres Nanotrap Capture and Concentration Methods Ability to co-monitor and co-quantify multiple pathogens from a single sample Assays available for the QIAcuity® Platform Respiratory virus detection including: Influenza A, Influenza B and RSV in addition to SARS-CoV-2 INTRODUCTION Monitoring the spread of […]

Monitoring the spread of SARS-CoV-2, the virus that causes COVID-19, as well as other pathogens such as RSV and Influenza continues to provide vital information for interrupting chains of transmission and preventing or dampening the spread of new cases. Wastewater testing continues to gain traction as a viable means to monitor pathogens and provide timely information about the changing prevalence within individual communities.

Signals in wastewater testing data can give hospitals and public health officials advance warning of an infectious disease outbreak. With this relatively simple “heads up,” preparations can begin days before the first patient walks through the doors of a clinic.

Multiplexed SARS-CoV-2, Influenza A/B, and RSV and Poliovirus Typing Assays (1, 2 and 3) for the Bio-Rad, QIAGEN, and Thermo PCR Platforms FORT COLLINS, Colo., Dec. 20, 2022 /PRNewswire/ — GT Molecular, a company providing ultrasensitive PCR assays and national testing services for wastewater-based epidemiology, cancer, and pathogens, is releasing a series of high-performance Respiratory Panels and Polio […]

In recent years, public health officials have affirmed the need for robust methods capable of proactive detection of pathogens to alert to outbreaks and limit spread of disease. Longitudinal studies using GT Molecular’s ddPCR™ PCR kits for Wastewater-based epidemiology (WBE) were demonstrated as capable and effective tools for SARS-CoV-2 outbreak monitoring and have recently been shown to be useful in detecting hMPXV (the virus responsible for human monkeypox).

dPCR Testing and Rapid NGS Services for Wastewater FORT COLLINS, Colo., July 28, 2022 /PRNewswire/ — GT Molecular, a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels has implemented a highly sensitive, wastewater-based test for hMPXV.  This test features robust quality control metrics, including an internal process control and fecal indicator. Current offerings: […]

The workflow leverages QIAGEN’s sample-preparation expertise and its innovative QIAcuity digital PCR system, which hosts GT Molecular’s digital SARS-CoV-2 Wastewater Surveillance Assay. The assay was developed to comply with the CDC guidelines for the United States National Wastewater Surveillance System (NWSS). The complete workflow has become available as of the beginning of August, when the […]

When the first reports of the B.1.1.7 variant emerged in December, GT Molecular, a company in Fort Collins, Colorado, was the first to reformat its sewage test to search for the variant. That involves checking sewage for two mutations characteristic of the B.1.1.7 strain.